171 related articles for article (PubMed ID: 16716123)
1. Treatment options for invasive fungal infections.
Dodds Ashley ES
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):55S-60S. PubMed ID: 16716123
[TBL] [Abstract][Full Text] [Related]
2. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
Sobel JD
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
[TBL] [Abstract][Full Text] [Related]
3. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
4. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
5. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of new antifungal agents.
Kauffman CA
Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
[TBL] [Abstract][Full Text] [Related]
7. Antifungal drugs.
Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
[No Abstract] [Full Text] [Related]
8. Micafungin (Mycamine) for fungal infections.
Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968
[TBL] [Abstract][Full Text] [Related]
9. New antifungal agents in pediatric practice.
Das S; Shivaprakash MR; Chakrabarti A
Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570
[TBL] [Abstract][Full Text] [Related]
10. Antifungal drugs.
Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
[No Abstract] [Full Text] [Related]
11. [Echinocandins in invasive candidiasis].
Glöckner A; Cornely OA
Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
[TBL] [Abstract][Full Text] [Related]
12. Fungal infections in neonates: update on prevention and treatment.
Kaufman DA
Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
[TBL] [Abstract][Full Text] [Related]
13. [Amphotericin B: the end of an era].
Oude Lashof AM; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116
[TBL] [Abstract][Full Text] [Related]
14. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
15. Empirical antifungal therapy in treating febrile neutropenic patients.
Wingard JR
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
[TBL] [Abstract][Full Text] [Related]
16. Focus on fungal infections.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
[TBL] [Abstract][Full Text] [Related]
17. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
18. [Potential of anidulafungin in combined therapy].
Gadea I; Mensa J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():51-5. PubMed ID: 19572435
[TBL] [Abstract][Full Text] [Related]
19. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
Nivoix Y; Zamfir A; Lutun P; Kara F; Remy V; Lioure B; Rigolot JC; Entz-Werlé N; Letscher-Bru V; Waller J; Levêque D; Koffel JC; Beretz L; Herbrecht R
J Infect; 2006 Jan; 52(1):67-74. PubMed ID: 16368463
[TBL] [Abstract][Full Text] [Related]
20. [Potential of anidulafungin in hematological patients].
Vázquez López L; Ruiz Camps I
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
